Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Granulosa Cell Tumor

ClinicalTrials.gov lists 3 trials for Granulosa Cell Tumor or a narrower condition beneath it.

MeSH D006106 Neoplasms Neoplasm C04 C12 C19
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 3 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 2 Publications Publications 8 Prevalence Prevalence 2 Rare-disease identity Rare-disease identity 2 Trials started per year Trials started per year 3 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 2 Publications Publications 8 Prevalence Prevalence 2 Rare-disease identity Rare-disease identity 2

Rows recorded per section

3 sections measured, none recorded · 1 not measured yet · 1 not computed

3 of the 3 trials are tagged with Granulosa Cell Tumor itself; the rest are tagged with a narrower condition beneath it.

Get the Granulosa Cell Tumor report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Granulosa Cell Tumor trials start? (3)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 2

Top of scale: 1

2012: 1 trials (Phase 2 1) 2014: 1 trials (Phase 2 1) 2024: 1 trials (Phase 2 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2024 1
2014 1
2012 1

No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Granulosa Cell Tumor trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Phase 2 3

How many Granulosa Cell Tumor trials are recruiting? (2)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 1
Terminated 2

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which publications cover Granulosa Cell Tumor? (8)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Prevalence (2)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Malignant granulosa cell tumor of the ovary Annual incidence 1-9 / 1 000 000 Europe Not stated Exact
Malignant granulosa cell tumor of the ovary Annual incidence 1-9 / 1 000 000 Europe Not stated Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Malignant granulosa cell tumor of the ovary 99915 Exact Orphanet Rare Disease Ontology (ORDO)
Malignant granulosa cell tumor of the ovary 99915 Exact Orphadata Science knowledge files, Product 1

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages